142 related articles for article (PubMed ID: 30180922)
1. 1,25(OH)2D3 Attenuates IL-1β-Induced Epithelial-to-Mesenchymal Transition Through Inhibiting the Expression of lncTCF7.
Li T; Zhu J; Zuo S; Chen S; Ma J; Ma Y; Guo S; Wang P; Liu Y
Oncol Res; 2019 Jul; 27(7):739-750. PubMed ID: 30180922
[TBL] [Abstract][Full Text] [Related]
2. Long noncoding RNA lncTCF7, induced by IL-6/STAT3 transactivation, promotes hepatocellular carcinoma aggressiveness through epithelial-mesenchymal transition.
Wu J; Zhang J; Shen B; Yin K; Xu J; Gao W; Zhang L
J Exp Clin Cancer Res; 2015 Oct; 34():116. PubMed ID: 26452542
[TBL] [Abstract][Full Text] [Related]
3. Dynamics of 1α,25-dihydroxyvitamin D3-dependent chromatin accessibility of early vitamin D receptor target genes.
Seuter S; Pehkonen P; Heikkinen S; Carlberg C
Biochim Biophys Acta; 2013 Dec; 1829(12):1266-75. PubMed ID: 24185200
[TBL] [Abstract][Full Text] [Related]
4. Vitamin D/VDR signaling inhibits LPS-induced IFNγ and IL-1β in Oral epithelia by regulating hypoxia-inducible factor-1α signaling pathway.
Ge X; Wang L; Li M; Xu N; Yu F; Yang F; Li R; Zhang F; Zhao B; Du J
Cell Commun Signal; 2019 Feb; 17(1):18. PubMed ID: 30813930
[TBL] [Abstract][Full Text] [Related]
5. MART-10, a less calcemic vitamin D analog, is more potent than 1α,25-dihydroxyvitamin D3 in inhibiting the metastatic potential of MCF-7 breast cancer cells in vitro.
Chiang KC; Chen SC; Yeh CN; Pang JH; Shen SC; Hsu JT; Liu YY; Chen LW; Kuo SF; Takano M; Kittaka A; Sun CC; Juang HH; Chen TC
J Steroid Biochem Mol Biol; 2014 Jan; 139():54-60. PubMed ID: 24125734
[TBL] [Abstract][Full Text] [Related]
6. Vitamin D₃ metabolites enhance the NLRP3-dependent secretion of IL-1β from human THP-1 monocytic cells.
Tulk SE; Liao KC; Muruve DA; Li Y; Beck PL; MacDonald JA
J Cell Biochem; 2015 May; 116(5):711-20. PubMed ID: 25639477
[TBL] [Abstract][Full Text] [Related]
7. Vitamin D and systemic cancer: is this relevant to malignant melanoma?
Osborne JE; Hutchinson PE
Br J Dermatol; 2002 Aug; 147(2):197-213. PubMed ID: 12174089
[TBL] [Abstract][Full Text] [Related]
8. The human peroxisome proliferator-activated receptor delta gene is a primary target of 1alpha,25-dihydroxyvitamin D3 and its nuclear receptor.
Dunlop TW; Väisänen S; Frank C; Molnár F; Sinkkonen L; Carlberg C
J Mol Biol; 2005 Jun; 349(2):248-60. PubMed ID: 15890193
[TBL] [Abstract][Full Text] [Related]
9. 1,25(OH)2D3 treatment attenuates high glucose‑induced peritoneal epithelial to mesenchymal transition in mice.
Yang L; Fan Y; Zhang X; Huang W; Ma J
Mol Med Rep; 2017 Oct; 16(4):3817-3824. PubMed ID: 28765896
[TBL] [Abstract][Full Text] [Related]
10. Co-expression of 1α-hydroxylase and vitamin D receptor in human articular chondrocytes.
Hansen AK; Figenschau Y; Zubiaurre-Martinez I
BMC Musculoskelet Disord; 2017 Nov; 18(1):432. PubMed ID: 29110708
[TBL] [Abstract][Full Text] [Related]
11. 1,25-Dihydroxyvitamin D3 (1,25(OH)2D3) Signaling Capacity and the Epithelial-Mesenchymal Transition in Non-Small Cell Lung Cancer (NSCLC): Implications for Use of 1,25(OH)2D3 in NSCLC Treatment.
Upadhyay SK; Verone A; Shoemaker S; Qin M; Liu S; Campbell M; Hershberger PA
Cancers (Basel); 2013 Nov; 5(4):1504-21. PubMed ID: 24217116
[TBL] [Abstract][Full Text] [Related]
12. Mineralization of three-dimensional osteoblast cultures is enhanced by the interaction of 1α,25-dihydroxyvitamin D3 and BMP2 via two specific vitamin D receptors.
Chen J; Dosier CR; Park JH; De S; Guldberg RE; Boyan BD; Schwartz Z
J Tissue Eng Regen Med; 2016 Jan; 10(1):40-51. PubMed ID: 23784946
[TBL] [Abstract][Full Text] [Related]
13. 1,25(OH)2D3 attenuates TGF-β1/β2-induced increased migration and invasion via inhibiting epithelial-mesenchymal transition in colon cancer cells.
Chen S; Zhu J; Zuo S; Ma J; Zhang J; Chen G; Wang X; Pan Y; Liu Y; Wang P
Biochem Biophys Res Commun; 2015 Dec 4-11; 468(1-2):130-5. PubMed ID: 26523511
[TBL] [Abstract][Full Text] [Related]
14. 1,25-Dihydroxyvitamin D3 stimulates cyclic vitamin D receptor/retinoid X receptor DNA-binding, co-activator recruitment, and histone acetylation in intact osteoblasts.
Kim S; Shevde NK; Pike JW
J Bone Miner Res; 2005 Feb; 20(2):305-17. PubMed ID: 15647825
[TBL] [Abstract][Full Text] [Related]
15. The vitamin D hormone and its nuclear receptor: molecular actions and disease states.
Haussler MR; Haussler CA; Jurutka PW; Thompson PD; Hsieh JC; Remus LS; Selznick SH; Whitfield GK
J Endocrinol; 1997 Sep; 154 Suppl():S57-73. PubMed ID: 9379138
[TBL] [Abstract][Full Text] [Related]
16. IL-6 Impairs the Activity of Vitamin D3 in the Regulation of Epithelial-Mesenchymal Transition in Triple Negative Breast Cancer.
Abdel-Mohsen MA; Abo Deif SM; Abou-Shamaa LA
Asian Pac J Cancer Prev; 2019 Aug; 20(8):2267-2273. PubMed ID: 31450894
[TBL] [Abstract][Full Text] [Related]
17. Inhibition of 1,25-dihydroxyvitamin D3 stimulated osteocalcin gene transcription by tumor necrosis factor-alpha: structural determinants within the vitamin D response element.
Kuno H; Kurian SM; Hendy GN; White J; deLuca HF; Evans CO; Nanes MS
Endocrinology; 1994 Jun; 134(6):2524-31. PubMed ID: 8194478
[TBL] [Abstract][Full Text] [Related]
18. Protective effect of 1α,25-dihydroxyvitamin D3 on effector CD4+ T cell induced injury in human renal proximal tubular epithelial cells.
Chung BH; Kim BM; Doh KC; Cho ML; Kim KW; Yang CW
PLoS One; 2017; 12(2):e0172536. PubMed ID: 28245293
[TBL] [Abstract][Full Text] [Related]
19. Vitamin D inhibits the epithelial-mesenchymal transition by a negative feedback regulation of TGF-β activity.
Ricca C; Aillon A; Viano M; Bergandi L; Aldieri E; Silvagno F
J Steroid Biochem Mol Biol; 2019 Mar; 187():97-105. PubMed ID: 30465855
[TBL] [Abstract][Full Text] [Related]
20. Vitamin D receptor activation down-regulates the small heterodimer partner and increases CYP7A1 to lower cholesterol.
Chow EC; Magomedova L; Quach HP; Patel R; Durk MR; Fan J; Maeng HJ; Irondi K; Anakk S; Moore DD; Cummins CL; Pang KS
Gastroenterology; 2014 Apr; 146(4):1048-59. PubMed ID: 24365583
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
